Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Fioricet with Codeine
This is a combination product of butalbital, acetaminophen, caffeine and codeine used to for relief of the symptomatic complex of tension or muscle contraction headache. Brand names include Fioricet® with Codeine; Phrenilin® with Caffeine and Codeine.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Headaches | 11 | 3 |
|
|
|||
| Migraine headaches | 4 | 2 |
|
||||
| Migraine | 2 | 0 | |||||
| Pain | 1 | 0 | |||||
| Migraine with aura | 1 | 0 | |||||
| Pain throughout body | 1 | 1 |
|
See all 21 patients currently taking Butalbital-acetaminophen-caffeine-codeine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Butalbital-acetaminophen-caffeine-codeine
| Fatigue | 1 | |
|---|---|---|
| Burning sensation | 1 | |
| Tiredness | 1 |
Frequently reported dosages based on patients currently taking Butalbital-acetaminophen-caffeine-codeine. See all 13 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 1 | ||
| Course of treatment ended | 1 | ||
| Not indicated | 1 |
See all 2 patients who’ve stopped taking Butalbital-acetaminophen-caffeine-codeine
Currently Taking Butalbital-acetaminophen-caffeine-codeine
A bar graph
Adherence
Taking treatment as prescribed
Adherence of Butalbital-acetaminophen-caffeine-codeine
Always |
3 | 60% |
|
|---|---|---|---|
Usually |
1 | 20% |
|
Sometimes |
1 | 20% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Butalbital-acetaminophen-caffeine-codeine
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 20% |
|
A little |
2 | 40% |
|
Not at all |
2 | 40% |
|
Cost
Paid out of pocket
Cost of Butalbital-acetaminophen-caffeine-codeine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 20% |
|
$25-49 |
1 | 20% |
|
< $25 |
3 | 60% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 10, 2012.